Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Shire exercises option to license candidate agent for CNS disorders

March 21, 2012

Cellceutix enters collaboration agreement to support Kevetrin development

March 20, 2012

CUNY to validate diagnostic antibodies

March 20, 2012

QRxPharma and Actavis sign new licensing agreement

March 20, 2012

Merck & Co. enters into collaboration to create new institute

March 20, 2012

Cartagenia enters partnership for rare epilepsy syndromes

March 20, 2012

Thrombogenics and Alcon enter commercialization agreement for ocriplasmin

March 16, 2012

Biogen Idec and MAKScientific enter MS agreement

March 16, 2012

Almirall attains new marketing rights to Sativex

March 16, 2012

Marina Biotech and ProNAi Therapeutics enter license agreement for DNAi-based therapies

March 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...